Intent Solutions

What Intent Solutions does

Intent Solutions, Inc. is an Atlanta-based medical device company founded in 2013 that developed the tad (take as directed) system, an FDA-registered Class 1 secure pill dispensing device. The handheld dispenser, slightly larger than a deck of playing cards, holds up to a 30-day supply of medication, is filled and programmed by a pharmacist, and releases pills only on the programmed schedule to the intended recipient via fingerprint biometric authentication. A tamper-proof enclosure and integrated AT&T LTE-M cellular connectivity (introduced in 2020) stream near real-time adherence data to a cloud-based portal, removing the prior requirement for Bluetooth pairing with a patient smartphone. A companion smartphone app provides dosing reminders and patient-facing usage data; clinicians, physicians, and clinical trial operators access dashboards with exception reporting to monitor compliance.

The company targets three primary use cases: clinical trials (where tad provides auditable pill-by-pill compliance data to reduce attrition and improve trial outcomes), patient adherence (Hepatitis C treatment, medication-assisted treatment for opioid use disorder, home-based oncology, and cardiac regimens), and opioid control (preventing misuse, abuse, and diversion of controlled substances). Notable deployments include the University of Kentucky's Kentucky Viral Hepatitis Treatment Study (KeY Treat), a federally funded $15 million program in which tad devices dispensed medication to 900 individuals over a 12-week course, with Gilead Sciences donating approximately $20M of medication. AT&T featured Intent Solutions in a 2020 technology blog focused on the opioid crisis.

Intent Solutions generates revenue through the sale or rental of the tad hardware bundled with a cloud-connected software subscription supporting recurring portal access and ongoing refill cycles. The go-to-market is enterprise B2B direct sales led by the executive team and the Chief Commercial Officer, targeting healthcare systems, research institutions, pharmacy networks, and federally funded public health programs. Pricing is not publicly disclosed and is contracted per engagement. The company is privately held, has disclosed approximately $4.18M in equity funding across two rounds (2016 and 2017), and operates with a small team of 1–10 employees including a fractional COO and fractional Quality Engineer.

Name

Intent Solutions

Legal name

Intent Solutions, Inc.

Website

https://intentsolutions.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Intent Solutions is an Atlanta-based medical device company that markets tad, an FDA-registered, fingerprint-secured pill dispenser with cellular connectivity that transmits real-time medication adherence data to clinicians, serving clinical trials, patient adherence programs, and opioid control initiatives.

Ownership category

akta.pro rank

Product category

Medication Adherence Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

akta.pro secondary industries

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Remote Adherence Monitoring & Smart Dispenser Services (HSABALAI), Medication Adherence, Reminders & Patient Support (HLACAKAF), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Medical device
• Medication adherence
• Smart pill dispenser
• Opioid control
• Clinical trial monitoring

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. tad Device and Software Subscription: Intent Solutions generates revenue through the sale/rental of its tad secure pill dispensing hardware combined with a cloud-connected software application. The device is filled and programmed by pharmacists and is used across clinical trials, patient adherence programs, and opioid control applications. Revenue is recurring as devices are replenished with prescription refills and ongoing software/data portal access is provided.
2. Pharmaceutical/Healthcare Program Contracts: Intent Solutions secures contracts with large healthcare programs (e.g., University of Kentucky's $15M federal grant for hepatitis C elimination) where tad technology is deployed to manage dispensation and track adherence for hundreds to thousands of patients. These government and institutional contracts represent significant B2B revenue engagements.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Intent Solutions sells the tad™ (Take As Directed) system — an FDA-registered Class 1 medical device consisting of a locked, fingerprint-authenticated, handheld pill dispenser (up to a 30-day supply), a companion smartphone app, and a cloud-based adherence data portal. The device tracks prescription adherence in near real time and is sold/leased on a subscription basis to healthcare providers, clinical trial sponsors, and government public health programs.

Product overview

Intent Solutions offers a unified product ecosystem centered on tad™ (Take As Directed), which comprises three integrated components: a secure fingerprint-authenticated pill dispensing device (tad), a companion smartphone application for patient reminders and data viewing, and a cloud-based data portal for clinicians to monitor adherence. The system addresses medication adherence across three primary applications: clinical trials, patient adherence programs, and opioid control.

Differentiator

Problem solved

Functional benefit

Brands

• tad™: Advanced adherence technology - a secure pill dispensing device with fingerprint identification that ensures the right dose is delivered to the right person at the right time. Tracks patient compliance and sends data to clinicians in near real-time.

Products and services

• tad (Take As Directed) Secure Pill Dispenser An FDA-registered Class 1 medical device: a secure, locked, handheld pill dispenser slightly larger than a deck of playing cards that holds up to a 30-day pill supply. It requires fingerprint biometric authentication to dispense, ensuring the right dose reaches the right person at the right time, and transmits adherence data in near real time. Sold/leased to healthcare providers, clinical trial sponsors, and government public health programs.
• tad Cloud-Based Data Portal A secure, cloud-based interface that streams near real-time adherence data from the tad dispenser to clinicians, pharmacists, physicians, and clinical trial project managers via user-friendly dashboards and exception reporting.
• tad Smartphone App A companion mobile application connected to the tad dispenser that delivers medication reminders and alerts to patients and allows users to view prescription information and usage data.

Quantifiable outcome

• Nearly half of all prescriptions are not taken as directed, resulting in over 125,000 annual deaths in the United States from adherence-related causes and a $637B annual revenue loss to the global pharmaceutical industry.
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• AT&TcoreTechnology or Integration · 22 November 2019Intent Solutions collaborated with AT&T to integrate LTE-M cellular technology into the new release of the tad dispensing system. AT&T's LTE-M low-power wide-area network enables tad devices to connect out of the box without Bluetooth pairing or Wi-Fi setup, streaming near real-time prescription adherence data directly to clinicians and healthcare providers. AT&T's deployment across the US and Mexico with carrier-grade security supports tad's connectivity in diverse settings including patients without smartphones.
• University of KentuckyflagshipStrategic or Co-development Partner · 1 July 2019Intent Solutions partnered with the University of Kentucky to deploy its tad medication dispensing system in the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a $15M federal grant program funded by the National Cancer Institute and National Institute on Drug Abuse. tad devices are used to dispense hepatitis C medications to 900 individuals in Perry County, Kentucky, over a 12-week treatment regimen, tracking patient adherence to help eradicate HCV from the county. The partnership represents a significant real-world deployment validating tad's application beyond opioid control into population health initiatives.
• Gilead SciencescoreOthers · 1 July 2019Gilead Sciences donated hepatitis C medications valued at approximately $20M for the Kentucky Viral Hepatitis Treatment Study (KeY Treat) program managed by Intent Solutions in partnership with the University of Kentucky. The donation enabled the $15M federal grant program to proceed without medication acquisition costs, directly supporting tad's deployment in tracking adherence for the 900 individuals in the program.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• AdhereTech: AdhereTech makes connected smart pill bottles that track and confirm medication adherence in real time, used in clinical trials and specialty pharma programs. Highly comparable to Intent Solutions' tad in use case, target buyers (pharma sponsors, health systems), and connected-device business model.
• Hero Health: Hero is a direct-to-consumer in-home smart pill dispenser that sorts, dispenses, and reminds patients to take medications, with a companion app for caregivers. Comparable to tad as a connected, secure, automated pill dispenser serving patient-adherence use cases, though DTC vs. B2B differs.
• MedMinder: MedMinder offers a connected pillbox/dispenser for patients with complex medication regimens, with adherence alerts and remote monitoring for caregivers and providers. Directly comparable to tad's patient-adherence and remote-monitoring proposition in elder and chronic-care populations.
• etectRx: etectRx's ID-Cap system uses an ingestible sensor embedded in pills plus a wearable reader to confirm ingestion events, primarily for clinical trials. Comparable to tad in pharma clinical-trial adherence and real-time ingestion-event data, but uses a different (ingestible) technical approach.
• Spencer Health Solutions: Spencer Health Solutions provides a connected in-home medication dispenser and patient-engagement platform for pharma, providers, and payers. Comparable to tad as a connected, multi-dose dispenser serving medication-adherence, clinical-trial, and population-health use cases.
• PharmRight (Livi): PharmRight's Livi is a connected, multi-compartment medication dispenser designed for home use, with adherence data shared with caregivers and providers. Comparable to tad in secure in-home dispensing and remote adherence monitoring.
• AARDEX Group (MEMS): AARDEX Group's MEMS is the long-standing gold standard for electronic medication adherence monitoring in clinical trials, using smart caps and bottle attachments. Directly comparable to tad in clinical-trial adherence data capture and pharma sponsor customer base.

Broad incumbents

• Phillips Medication Dispensing Service (Philips): Philips' medication dispensing service is an in-home automated dispenser from a large established healthcare technology incumbent. Comparable in end-use (secure in-home pill dispensing, adherence for elderly/chronic patients), but operates as part of a much broader healthcare portfolio rather than a focused adherence vendor.
• Omnicell: Omnicell is a large medication management and pharmacy automation vendor serving hospitals, health systems, and retail pharmacies. Comparable to Intent Solutions as a participant in medication management/adherence infrastructure, but at a vastly larger scale and broader scope than tad.

Emerging players

• Propeller Health (ResMed): Propeller Health (owned by ResMed) makes connected inhaler sensors and digital therapeutics platforms for respiratory medication adherence. Comparable to tad as a connected adherence device + cloud data platform sold to pharma sponsors and providers, but focused on inhaled drugs rather than oral solid-dose medications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/solutionsintent
• LinkedInlinkedin.com/company/intent-solutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intent Solutions